Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines
Karolin Ebert(TUM Klinikum), Birgit Luber(TUM Klinikum)
Cited by 12
Related Papers
Relationship between E‐cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl‐2 expression and Ki‐67 staining in diffuse‐type gastric carcinoma
|International Journal of Cancer|2003|42
Prognostic significance of p21 <sup>WAF1/CIP1</sup> , p27 <sup>Kip1</sup> , p53 and E-cadherin expression in gastric cancer
|Journal of Clinical Pathology|2007|39
Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines
|International Journal of Oncology|2012|39
MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells
|PLoS ONE|2019|29
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines
|Molecular Oncology|2018|28